According to FutureWise analysis the market for albumin and creatinine tests in 2023 is US$ 1.56 billion, and is expected to reach US$ 5.31 billion by 2031 at a CAGR of 16.50%.
The microalbumin creatinine ratio test is a diagnostic procedure that involves assessing minute amounts of a protein called albumin in a urine sample. This protein, also called microalbumin, can be an early indicator of kidney disease. Essentially, healthy kidneys possess fine filters preventing substantial albumin molecules from excreting urine. Typically, only trace amounts of albumin, or none, pass through these filters. However, more albumin may enter the urine if the kidneys are compromised. Creatinine is a natural waste product from muscle metabolism, which is also found in urine. The microalbumin creatinine ratio test compares the albumin levels to creatinine in the urine, providing a more precise measure of albumin excretion. Healthcare providers can estimate the 24-hour albumin excretion based on the results of a single urine sample. This test is especially crucial for individuals with a higher risk of kidney disease, including those with diabetes, high blood pressure, a family history of kidney disease, heart conditions, individuals over 50, smokers, and those who are obese. Detecting kidney disease early allows for timely intervention and treatment. The procedure involves collecting a urine sample, which can be done in various ways: through a random or spot sample, an early morning or timed sampling, or a 24-hour collection. It's essential to follow specific instructions for urine collection to prevent contamination.
Before the test, individuals may be advised to abstain from intense exercise or consuming meat, as these factors can affect test results. It's important to discuss any medications or supplements being taken, as they may impact the test outcome. No known risks are associated with providing a urine sample for this test. However, individuals with conditions like haemorrhoids or those menstruating should inform their healthcare provider before the test.
FutureWise Market Research has published a report that provides an insightful analysis of Albumin and Creatinine Tests Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Albumin and Creatinine Tests Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.